Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach
暂无分享,去创建一个
[1] A. Kurtul,et al. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention , 2021, Acta cardiologica.
[2] E. Navarese,et al. State of the Art: No-Reflow Phenomenon. , 2020, Cardiology clinics.
[3] T. Behl,et al. No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients , 2020, Journal of clinical medicine.
[4] H. Landsheer. Uncertain Interval Methods for Three-Way Cut-Point Determination in Test Results [R package UncertainInterval version 0.6.0] , 2020 .
[5] R. Irizarry. ggplot2 , 2019, Introduction to Data Science.
[6] T. Morita,et al. P589Prognostic value of systemic immune-inflammation index in patients with chronic heart failure , 2018, European Heart Journal.
[7] J. Fajar,et al. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis , 2018, Indian heart journal.
[8] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[9] Rachel V. Stankowski,et al. Management of No-Reflow Phenomenon in the Catheterization Laboratory. , 2017, JACC. Cardiovascular interventions.
[10] J. Landsheer. Interval of Uncertainty: An Alternative Approach for the Determination of Decision Thresholds, with an Illustrative Application for the Prediction of Prostate Cancer , 2016, PloS one.
[11] Sanjiv Gupta,et al. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction , 2016, Indian heart journal.
[12] W. Guo,et al. Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma , 2014, Clinical Cancer Research.
[13] M. B. Demirçelik,et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. , 2014, The American journal of cardiology.
[14] G. Gioia,et al. No-Reflow Phenomenon , 2014, Angiology.
[15] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[16] Michail I. Papafaklis,et al. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. , 2010, The Journal of invasive cardiology.
[17] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[18] F. Burzotta,et al. Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.
[19] R. Jaffe,et al. Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention , 2008, Circulation.
[20] T. Hafez. Modification of Diet in Renal Disease (MDRD) estimated glomerular filtration rate (eGFR) formula. , 2007, The American journal of cardiology.
[21] D. Rott. Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect. , 2005, Journal of the American College of Cardiology.
[22] Jacques Pouchot,et al. A grey zone for quantitative diagnostic and screening tests. , 2003, International journal of epidemiology.
[23] Y. Taniyama,et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. , 1996, Circulation.
[24] D B Matchar,et al. Likelihood ratios for continuous test results--making the clinicians' job easier or harder? , 1993, Journal of clinical epidemiology.
[25] J. Jamart. Chance-corrected sensitivity and specificity for three-zone diagnostic tests. , 1992, Journal of clinical epidemiology.
[26] A R Feinstein,et al. The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. , 1990, Journal of clinical epidemiology.
[27] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.